Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats

Toxicological Sciences

Volumn 127, Issue 1, 2012, Pages 256-268

  Yokel, Robert A ^a,b   Au, Tu C ^a   MacPhail, Robert ^c   Hardas, Sarita S ^b   Butterfield, D Allan ^b   Sultana, Rukhsana ^b   Goodman, Michael ^b   Tseng, Michael T ^d   Dan, Mo ^a,b   Haghnazar, Hamed ^a   Unrine, Jason M ^e   Graham, Uschi M ^b   Wu, Peng ^f   Grulke, Eric A ^f  

^a University of Kentucky   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^d University of Louisville School of Medicine   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

^f UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Ceria; Excretion; Rat; Retention; Tissue distribution

Indexed keywords

CERIUM; METAL OXIDE; NANOMATERIAL;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE MARROW; CEREBROSPINAL FLUID; CONTROLLED STUDY; DISPERSION; HISTOLOGY; MALE; MONONUCLEAR PHAGOCYTE; NONHUMAN; OXIDATIVE STRESS; RAT; SPLEEN WEIGHT; URINE VOLUME;

EID: 84860169223     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfs067     Document Type: Article

References (72)

1. Auffan, M., Rose, J., Orsiere, T., de Meo, M., Thill, A., Zeyons, O., Proux, O., Masion, A., Chaurand, P., Spalla, O., et al. (2009). CeO2 nanoparticles induce DNA damage towards human dermal fibroblasts in vitro. Nanotoxicology 3, 161-171.
2. Babu, S., Cho, J. H., Dowding, J. M., Heckert, E., Komanski, C., Das, S., Colon, J., Baker, C. H., Bass, M., Self, W. T., et al. (2010). Multicolored redox active upconverter cerium oxide nanoparticle for bio-imaging and therapeutics. Chem. Commun. (Camb.) 46, 6915-6917.
3. Ballou, B., Lagerholm, B. C., Ernst, L. A., Bruchez, M. P., and Waggoner, A. S. (2004). Noninvasive imaging of quantum dots in mice. Bioconjug. Chem. 15, 79-86.
4. Bouwmeester, H., Lynch, I., Marvin, H. J., Dawson, K. A., Berges, M., Braguer, D., Byrne, H. J., Casey, A., Chambers, G., Clift, M. J., et al. (2011). Minimal analytical characterization of engineered nanomaterials needed for hazard assessment in biological matrices. Nanotoxicology 5, 1-11.
5. Brunner, T. J., Wick, P., Manser, P., Spohn, P., Grass, R. N., Limbach, L. K., Bruinink, A., and Stark, W. J. (2006). In vitro cytotoxicity of oxide nanoparticles: Comparison to asbestos, silica, and the effect of particle solubility. Environ. Sci. Technol. 40, 4374-4381.
6. Butterfield, D. A. (1997). beta-Amyloid-associated free radical oxidative stress and neurotoxicity: Implications for Alzheimer's disease. Chem. Res. Toxicol. 10, 495-506.
7. Cassee, F. R., van Balen, E. C., Singh, C., Green, D., Muijser, H., Weinstein, J., and Dreher, K. (2011). Exposure, health and ecological effects review of engineered nanoscale cerium and cerium oxide associated with its use as a fuel additive. Crit. Rev. Toxicol. 41, 213-229.
8. 3+ ions determine redox-dependent anti-apoptotic effect of cerium oxide nanoparticles. ACS Nano 5, 4537-4549.
9. Chen, J., Patil, S., Seal, S., and McGinnis, J. F. (2006). Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides. Nat. Nanotechnol. 1, 142-150.
10. Chithrani, B. D., Ghazani, A. A., and Chan, W. C. (2006). Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett. 6, 662-668.
11. Cho, W. S., Duffin, R., Poland, C. A., Howie, S. E., MacNee, W., Bradley, M., Megson, I. L., and Donaldson, K. (2010). Metal oxide nanoparticles induce unique inflammatory footprints in the lung: Important implications for nanoparticle testing. Environ. Health Perspect. 118, 1699-1706.
12. Choi, H. S., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., and Frangioni, J. V. (2007). Renal clearance of quantum dots. Nat. Biotechnol. 25, 1165-1170.
13. Choi, J., Reipa, V., Hitchins, V. M., Goering, P. L., and Malinauskas, R. A. (2011). Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol. Sci. 123, 133-143.
14. Choi, J. Y., Ramachandran, G., and Kandlikar, M. (2009). The impact of toxicity testing costs on nanomaterial regulation. Environ. Sci. Technol. 43, 3030-3034.
15. Colon, J., Hsieh, N., Ferguson, A., Kupelian, P., Seal, S., Jenkins, D. W., and Baker, C. H. (2010). Cerium oxide nanoparticles protect gastrointestinal epithelium from radiation-induced damage by reduction of reactive oxygen species and upregulation of superoxide dismutase 2. Nanomedicine 6, 698-705.
16. D'Angelo, B., Santucci, S., Benedetti, E., Di Loreto, S., Phani, R. A., Falone, S., Amicarelli, F., Ceru, M. P., and Cimini, A. (2009). Cerium oxide nanoparticles trigger neuronal survival in a human Alzheimer disease model by modulating BDNF pathway. Curr. Nanosci. 5, 167-176.
17. Das, M., Patil, S., Bhargava, N., Kang, J. F., Riedel, L. M., Seal, S., and Hickman, J. J. (2007). Auto-catalytic ceria nanoparticles offer neuroprotection to adult rat spinal cord neurons. Biomaterials 28, 1918-1925.
18. Durbin, P. W., Williams, M. H., Gee, M., Newman, R. H., and Hamilton, J. G. (1956). Metabolism of the lanthanons in the rat. Proc. Soc. Exp. Biol. Med. 91, 78-85.
19. Estevez, A. Y., Pritchard, S., Harper, K., Aston, J. W., Lynch, A., Lucky, J. J., Ludington, J. S., Chatani, P., Mosenthal, W. P., Leiter, J. C., et al. (2011). Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Radic. Biol. Med. 51, 1155-1163.
20. Fabian, E., Landsiedel, R., Ma-Hock, L., Wiench, K., Wohlleben, W., and van Ravenzwaay, B. (2008). Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch. Toxicol. 82, 151-157.
21. Feng, X., Sayle, D. C., Wang, Z. L., Paras, M. S., Santora, B., Sutorik, A. C., Sayle, T. X., Yang, Y., Ding, Y., Wang, X., et al. (2006). Converting ceria polyhedral nanoparticles into single-crystal nanospheres. Science 312, 1504-1508.
22. Gehlhaus, M., Osier, M., Llados, F., Plewak, D., Lumpkin, M., Odin, M., and Rooney, A. (2009). Toxicological Review of Cerium Oxide and Cerium Compounds (CAS No. 1306-38-3) In support of Summary Information on the Integrated Risk Information System (IRIS). pp. 118. U.S. Environmental Protection Agency. Available at: http://www.epa.gov/iris/toxreviews/1018tr.pdf.
23. He, X., Zhang, H., Ma, Y., Bai, W., Zhang, Z., Lu, K., Ding, Y., Zhao, Y., and Chai, Z. (2010). Lung deposition and extrapulmonary translocation of nanoceria after intratracheal instillation. Nanotechnology 21, 285103/1-285103/8.
24. Health Effects Institute (HEI) (2001). Evaluation of Human Health Risk From Cerium Added to Diesel Fuel, Communication 9. Available at: http://pubs.healtheffects.org/getfile.php?u=295.
25. Hirst, S. M., Karakoti, A., Singh, S., Self, W., Tyler, R., Seal, S., and Reilly, C. M. (Forthcoming). Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice. Environ. Toxicol.
26. Hirst, S. M., Karakoti, A. S., Tyler, R. D., Sriranganathan, N., Seal, S., and Reilly, C. M. (2009). Anti-inflammatory properties of cerium oxide nanoparticles. Small 5, 2848-2856.
27. Hussain, S. M., Hess, K. L., Gearhart, J. M., Geiss, K. T., and Schlager, J. J. (2005). In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 19, 975-983.
28. Integrated Laboratory Systems (ILS). (2006). Chemical Information Profile for Ceric Oxide [CAS No. 1306-38-3]. Supporting Nomination for Toxicological Evaluation by the National Toxicology Program. National Toxicology Program. National Institute of Environmental Health Sciences, National Institutes of Health, U.S. Department of Health and Human Services, Research Triangle Park, NC. Available at: http://ntp.niehs.nih.gov/files/ceric_oxide2.pdf.
29. Jiang, J., Oberdörster, G., Elder, A., Gelein, R., Mercer, P., and Biswas, P. (2008). Does nanoparticle activity depend upon size and crystal phase? Nanotoxicology 2, 33-42.
30. Korsvik, C., Patil, S., Seal, S., and Self, W. T. (2007). Superoxide dismutase mimetic properties exhibited by vacancy engineered ceria nanoparticles. Chem. Commun. (Camb.) 1056-1058.
31. Lin, W., Huang, Y. W., Zhou, X. D., and Ma, Y. (2006). Toxicity of cerium oxide nanoparticles in human lung cancer cells. Int. J. Toxicol. 25, 451-457.
32. Loh, J. W., Yeoh, G., Saunders, M., and Lim, L.-Y. (2010). Uptake and cytotoxicity of chitosan nanoparticles in human liver cells. Toxicol. Appl. Pharmacol. 249, 148-157.
33. Mai, H.-X., Sun, L.-D., Zhang, Y.-W., Si, R., Feng, W., Zhang, H.-P., Liu, H.-C., and Yan, C.-H. (2005). Shape-selective synthesis and oxygen storage behavior of ceria nanopolyhedra, nanorods, and nanocubes. J. Phys. Chem. B 109, 24380-24385.
34. Maynard, A. D., Warheit, D. B., and Philbert, M. A. (2011). The new toxicology of sophisticated materials: Nanotoxicology and beyond. Toxicol. Sci. 120(Suppl. 1), S109-S129.
35. Miller, J. K., and Byrne, W. F. (1970). Absorption, excretion, and tissue distribution of orally and intravenously administered radiocerium as affected by EDTA. J. Dairy Sci. 53, 171-175.
36. Moghimi, S. M., Hunter, A. C., and Murray, J. C. (2001). Long-circulating and target-specific nanoparticles: Theory to practice. Pharmacol. Rev. 53, 283-318.
37. Molin, S., Gazda, M., Jasinski, P., and Nowakowski, A. (2008). Electrical properties of porous nanocrystalline undoped ceria oxygen sensor. Elektronika 49, 253-254.
38. Nel, A., Xia, T., Madler, L., and Li, N. (2006). Toxic potential of materials at the nanolevel. Science 311, 622-627.
39. Nel, A. E., Madler, L., Velegol, D., Xia, T., Hoek, E. M., Somasundaran, P., Klaessig, F., Castranova, V., and Thompson, M. (2009). Understanding biophysicochemical interactions at the nano-bio interface. Nat. Mater. 8, 543-557.
40. Niu, J., Azfer, A., Rogers, L. M., Wang, X., and Kolattukudy, P. E. (2007). Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy. Cardiovasc. Res. 73, 549-559.
41. Niu, J., Wang, K., and Kolattukudy, P. E. (2011). Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-kappaB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract. J. Pharmacol. Exp. Ther. 338, 53-61.
42. Organisation for Economic Co-operation and Development (OECD) (2010). List of Manufactured Nanomaterials and List of Endpoints for Phase One of the Sponsorship Programme for the Testing of Manufactured Nanomaterials: Revision. Environment Directorate, Pesticides and Biotechnology, Organisation for Economic Co-operation and Development. Paris. pp. 16, ENV/JM/ MONO(2010)46, http://www.oecd.org/officialdocuments/displaydocumentpdf?cote=env/jm/mono(2010)46&doclanguage=en.
43. Okon, E. E., Pulikan, D., Pereverzev, A. E., Kudriavtsev, B. N., and Zhale, P. (2000). Toxicity of magnetite-dextran particles: Morphological study. Tsitologiia 42, 358-366.
44. Park, B., Martin, P., Harris, C., Guest, R., Whittingham, A., Jenkinson, P., and Handley, J. (2007). Initial in vitro screening approach to investigate the potential health and environmental hazards of Envirox™-A nanoparticulate cerium oxide diesel fuel additive. Part. Fibre Toxicol. 4, 12.
45. Park, E. J., Choi, J., Park, Y. K., and Park, K. (2008). Oxidative stress induced by cerium oxide nanoparticles in cultured BEAS-2B cells. Toxicology 245, 90-100.
46. Park, E.-J., Park, Y.-K., and Park, K. (2009). Acute toxicity and tissue distribution of cerium oxide nanoparticles by a single oral administration in rats. Toxicol. Res. 25, 79-84.
47. Park, E.-J., Wan-Seob, C., Jeong, J., Yi, J.-H., Choi, K., Kim, Y., and Park, K. (2010). Induction of inflammatory responses in mice treated with cerium oxide nanoparticles by intratracheal instillation. J. Health Sci. 56, 387-396.
48. Patlolla, A., Berry, A., and Tchounwou, P. (2011). Study of hepatotoxicity and oxidative stress in male Swiss-Webster mice exposed to functionalized multi-walled carbon nanotubes. Mol. Cell. Biochem. 358, 189-199.
49. Pirmohamed, T., Dowding, J. M., Singh, S., Wasserman, B., Heckert, E., Karakoti, A. S., King, J. E., Seal, S., and Self, W. T. (2010). Nanoceria exhibit redox state-dependent catalase mimetic activity. Chem. Commun. (Camb.) 46, 2736-2738.
50. Powers, K. W., Palazuelos, M., Brown, S. C., and Roberts, S. M. (2009). Characterization of nanomaterials for toxicological evaluation. In Nanotoxicology From In Vivo and In Vitro Models to Health Risks. (S. Sahu and D. Casciano, Eds.), pp. 1-27. Wiley, Chichester, West Sussex, U.K.
51. Rodea-Palomares, I., Boltes, K., Fernandez-Pinas, F., Leganes, F., Garcia-Calvo, E., Santiago, J., and Rosal, R. (2011). Physicochemical characterization and ecotoxicological assessment of CeO2 nanoparticles using two aquatic microorganisms. Toxicol. Sci. 119, 135-145.
52. Roh, J. Y., Park, Y. K., Park, K., and Choi, J. (2010). Ecotoxicological investigation of CeO(2) and TiO(2) nanoparticles on the soil nematode Caenorhabditis elegans using gene expression, growth, fertility, and survival as endpoints. Environ. Toxicol. Pharmacol. 29, 167-172.
53. Sayes, C. M., Gobin, A. M., Ausman, K. D., Mendez, J., West, J. L., and Colvin, V. L. (2005). Nano-C60 cytotoxicity is due to lipid peroxidation. Biomaterials 26, 7587-7595.
54. Sayes, C. M., and Warheit, D. B. (2009). Characterization of nanomaterials for toxicity assessment. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1, 660-670.
55. Srinivas, A., Rao, P. J., Selvam, G., Murthy, P. B., and Reddy, P. N. (2011). Acute inhalation toxicity of cerium oxide nanoparticles in rats. Toxicol. Lett. 205, 105-115.
56. Stadtman, E. R. (2006). Protein oxidation and aging. Free Radic. Res. 40, 1250-1258.
57. Sultana, R., Ravagna, A., Mohmmad-Abdul, H., Calabrese, V., and Butterfield, D. A. (2005). Ferulic acid ethyl ester protects neurons against amyloid beta-peptide(1-42)-induced oxidative stress and neurotoxicity: Relationship to antioxidant activity. J. Neurochem. 92, 749-758.
58. Sung, J. H., Ji, J. H., Park, J. D., Yoon, J. U., Kim, D. S., Jeon, K. S., Song, M. Y., Jeong, J., Han, B. S., Han, J. H., et al. (2009). Subchronic inhalation toxicity of silver nanoparticles. Toxicol. Sci. 108, 452-461.
59. 2 nanoparticles for Escherichia coli. Physico-chemical insight of the cytotoxicity mechanism. Environ. Sci. Technol. 40, 6151-6156.
60. Tseng, M. T., Lu, X., Duan, X., Hardas, S. S., Sultana, R., Wu, P., Unrine, J. M., Graham, U., Butterfield, D. A., Grulke, E., et al. (2012). Hepatic structural and oxidative stress indices alteration by intravenous infusion of nanoceria. Toxicol. Appl. Pharmacol. 260, 173-182.
61. 2 nanoparticles in aquatic ecotoxicity tests. Environ. Sci. Technol. 43, 4537-4546.
62. Wang, J., Chen, B., Jin, N., Xia, G., Chen, Y., Zhou, Y., Cai, X., Ding, J., Li, X., and Wang, X. (2011). The changes of T lymphocytes and cytokines in ICR mice fed with Fe3O4 magnetic nanoparticles. Int. J. Nanomedicine 6, 605-610.
63. Wang, J., Chen, C., Lau, S., Raghavan, R. I., Rowsell, E. H., Said, J., Weiss, L. M., and Huang, Q. (2009). CD3-positive large B-cell lymphoma. Am. J. Surg. Pathol. 33, 505-512.
64. Warheit, D. B., Sayes, C. M., Reed, K. L., and Swain, K. A. (2008). Health effects related to nanoparticle exposures: Environmental, health and safety considerations for assessing hazards and risks. Pharmacol. Ther. 120, 35-42.
65. Xia, T., Kovochich, M., Liong, M., Madler, L., Gilbert, B., Shi, H., Yeh, J. I., Zink, J. I., and Nel, A. E. (2008). Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2, 2121-2134.
66. Yokel, R. A., Florence, R. L., Unrine, J. M., Tseng, M. T., Graham, U. M., Wu, P., Grulke, E. A., Sultana, R., Hardas, S. S., and Butterfield, D. A. (2009). Biodistribution and oxidative stress effects of a systemicallyintroduced commercial ceria engineered nanomaterial. Nanotoxicology 3, 234-248.
67. Younce, C. W., Wang, K., and Kolattukudy, P. E. (2010). Hyperglycaemiainduced cardiomyocyte death is mediated via MCP-1 production and induction of a novel zinc-finger protein MCPIP. Cardiovasc. Res. 87, 665-674.
68. Yuan, J., Gao, H., Sui, J., Chen, W. N., and Ching, C. B. (2011). Cytotoxicity of single-walled carbon nanotubes on human hepatoma HepG2 cells: An iTRAQ-coupled 2D LC-MS/MS proteome analysis. Toxicol. In Vitro 25, 1820-1827.
69. Yuan, Q., Duan, H.-H., Li, L.-L., Sun, L.-D., Zhang, Y.-W., and Yan, C.-H. (2009). Controlled synthesis and assembly of ceria-based nanomaterials. J. Colloid Interface Sci. 335, 151-167.
70. Zeyons, O., Thill, A., Chauvat, F., Menguy, N., Cassier-Chauvat, C., Orear, C., Daraspe, J., Auffan, M., Rose, J., and Spalla, O. (2009). Direct and indirect CeO2 nanoparticles toxicity for Escherichia coli and Synechocystis. Nanotoxicology 3, 284-295.
71. Zhang, H., He, X., Zhang, Z., Zhang, P., Li, Y., Ma, Y., Kuang, Y., Zhao, Y., and Chai, Z. (2010). Nano-CeO2 exhibits adverse effects at environmental relevant concentrations. Environ. Sci. Technol. 45, 3725-3730.
72. Zhou, X., Wong, L. L., Karakoti, A. S., Seal, S., and McGinnis, J. F. (2011). Nanoceria inhibit the development and promote the regression of pathologic retinal neovascularization in the Vldlr knockout mouse. PLoS One 6, e16733.